Urology

Your Article Summary

See Latest Articles

Risk factors for positive findings in patients with high-grade T1 bladder cancer treated with transurethral resection of bladder tumour (TUR) and bacille Calmette-Guerin therapy and the decision for a repeat TUR
BJU International, 06/26/09

Orsola A et al. - In initial HGT1-TCC, tumour size and CIS were predictive factors of positive findings at 3 months after the initial TUR + BCG therapy. Patients with HGT1-TCC invading the LP (T1b TCC) had a seven times higher risk of a positive repeat TUR if the initial tumour was >3 cm and a five-fold increased risk if associated with CIS. The repeat TUR after BCG therapy allowed confirmation of complete resection and pathological evaluation of the BCG response.

Today in Bladder...keeping you current

Receive free subspecialty "5-minute updates" via email

Randomized phase III trial on gemcitabine versus mytomicin in recurrent superficial bladder cancer: Evaluation of efficacy and tolerance
Journal of Clinical Oncology, 10/26/09

Fesoterodine: a new antimuscarinic for overactive bladder
Aging Health, 10/13/09

Frequently asked questions in the evaluation and management of overactive bladder
The Journal of Family Practice, 11/02/09

See All of Bladder

Today in Oncology...keeping you current

Receive free subspecialty "5-minute updates" via email

Risk of dying from prostate cancer in men randomized to screening
Cancer, 10/13/09

Zinc and prostatic cancer
Current Opinion in Clinical Nutrition & Metabolic Care, 10/14/09

Early PSA decrease is an independent predictive factor of clinical failure and specific survival in patients with localized prostate cancer treated by radiotherapy with or without androgen deprivation therapy
Annals of Oncology, 10/16/09

See All of Oncology